GSK hails positive results for linerixibat in treating relentless itch
(Alliance News) - GSK PLC on Tuesday said that its investigational targeted inhibitor linerixibat demonstrated sound results for a treatment of relentless itch. Read More
Price | 1,300.00p on 21-11-2024 | at 06:00:03
---|---|
Change | 0.00p 0% |
Buy | 1,398.00p |
Sell | 1,295.00p |
Buy / Sell GSK Shares |
Last Trade: | Unknown 4,240,788.00 at 1,306.50p |
Day's Volume: | 0 |
Last Close: | 1,300.00p |
Open: | 0.00p |
ISIN: | GB00BN7SWP63 |
Day's Range | 0.00p - 0.00p |
52wk Range: | 1,282.50p - 1,820.00p |
Market Capitalisation: | £53,046m |
VWAP: | 0.00p |
Shares in Issue: | 4,080m |
Recent Trades History Glaxosmithkline (GSK) |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Unknown* | 4,240,788 | 1,306.50p | OTC Trade |
00:00:00 - 20-Nov-24 |
Unknown* | -4,240,788 | 1,306.50p | Correction OTC Trade |
00:00:00 - 20-Nov-24 |
Unknown* | 4,240,788 | 1,306.50p | OTC Trade |
00:00:00 - 20-Nov-24 |
Unknown* | 1 | 1,302.00p | OTC Trade |
16:11:15 - 20-Nov-24 |
Unknown* | 1,650,879 | 1,306.50p | OTC Trade |
14:39:35 - 20-Nov-24 |
Unknown* | 1,650,879 | 1,306.50p | OTC Trade |
14:39:34 - 20-Nov-24 |
Buy* | 2,924 | 1,300.00p | Suspected BUY Trade |
16:37:46 - 20-Nov-24 |
Unknown* | 984 | 1,300.00p | SI Trade |
16:35:15 - 20-Nov-24 |
Unknown* | 963 | 1,300.00p | SI Trade |
16:35:15 - 20-Nov-24 |
Unknown* | 1,288 | 1,300.00p | SI Trade |
16:35:15 - 20-Nov-24 |